SynAScan 1 Blood Test
Enables reliable, accurate and non-invasive detection of Parkinson’s Disease
What Is Parkinson’s?
A quick look at the disease and how it affects the brain
Why Early Detection Matters?
Catching it early can help manage symptoms better
Current Challenges
Why it’s hard to diagnose Parkinson’s today
How Our Test Helps
A new way to find signs of Parkinson’s through blood
Transforming Parkinson’s Diagnosis
A revolutionary blood test built from cutting-edge research
Our mission is to bring lab breakthroughs to the clinic- starting with a blood-based diagnostic for Parkinson’s disease.
Who We Are
Revolutionizing Amyloid Disease Management
Amyscan envisions transforming the diagnosis and management of amyloid-based diseases by translating cutting-edge research into high-throughput and clinically accessible diagnostic tools. We aim to develop early and accurate amyloid detection technologies and build a new standard in patient care—one that facilitates timely intervention and paves the way for more effective treatment strategies.
Parkinson’s?
Understand Parkinson's Disease and How it is Diagnosed
Today, diagnosis relies largely on the clinical observation of motor and non-motor symptoms, identifying Parkinson’s-specific signs while ruling out other conditions with overlapping features. This process can be complex—making Parkinson’s diagnosis more of a journey than a moments
What We Offer - More than a Blood Test
Minimally
Invasive
Highly
Accurate
Clinically
Validated
